|
Office Locations:
|
3889 Maple Avenue
Parkland Hall, Suite 220
Dallas, TX 75219
Phone: 214-740-3610
Fax: 214-740-3630
| | |
|
|
|
Business Services
Energy & Clean Tech
Life Sciences & Healthcare
Manufacturing & Industrial
|
|
|
Founded in 1999, Parallel Investment Partners was established to create an institutional private equity firm dedicated exclusively to the needs of growing companies in North America's lower middle market. With over $600 million of institutional private equity capital commitments, Parallel targets equity investments of $10-$25 million and total enterprise values ranging from $10-100 million. The investment focus of Parallel is on Growth Company Recapitalizations, Buyouts and Growth Capital Investments, typically in companies with historical profitability of at least 10% and revenues of between $10 million and $100 million annually. Companies also need a current year EBITDA of at least $3 million with a three year history of positive cash flow. The firm has completed over 35 private equity investments in middle market growth companies across a number of industry categories including Business to Business, Consumer, Energy, Healthcare, and Specialty Manufacturing.
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|